New gene therapy could treat devastating heart failure
Researchers at Imperial College London have begun the first UK clinical trials of a gene therapy for heart failure. Heart failure, when the heart is unable to pump blood adequately, affects more than 750,000 people in the UK, causing breathlessness and hindering day-to-day activities. The therapy is designed to increase the levels of SERCA2a protein […]
